Cognitive Effects of Atomoxetine in Humans: Genetic Moderators
What is the purpose of this trial?
The overall goal of this study is to determine if atomoxetine treatment improves selective cognitive functions in abstinent cocaine users, compared to healthy controls. The study will also test if a functional variation of the NET promoter polymorphic region (NETpPR) moderates the cognitive effects of atomoxetine.
- 21 Years - 50 Years
- Yale University
- December 2011
- Last Updated:
- June 13, 2014
- Study HIC#:
Clinicaltrials.gov ID: NCT01498549